Nephro Care India IPO vs Visaman Global Sales IPO

Comparision between Nephro Care India IPO and Visaman Global Sales IPO.

IPO Details

Nephro Care India IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price Issue proposed to list at NSE SME.

	Nephro Care India IPO	Visaman Global Sales IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Fixed Price Issue
Listing At	NSE SME	NSE SME
Lead Managers	Corporate Capitalventures Pvt Ltd	Shreni Shares Limited
Registrar	Bigshare Services Pvt Ltd	Link Intime India Private Ltd
Market Maker	Ss Corporate Securities Limited	Shreni Shares Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Nephro Care India IPO is up to ₹41.26 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹16.05 Cr. The final issue price of Nephro Care India IPO is ₹90.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.

	Nephro Care India IPO	Visaman Global Sales IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹85.00 per share
Issue Price (Upper)	₹90.00 per share
Issue Price (Final)	₹90.00 per share	₹43.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1600 shares	3000 shares
Fresh Issue Size	45,84,000 shares	37,32,000 shares
Fresh Issue Size (Amount)	up to ₹41.26 Cr	up to ₹16.05 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	45,84,000 shares	37,32,000 shares
Issue Size Total (Amount)	up to ₹41.26 Cr	up to ₹16.05 Cr

IPO Timetable

Nephro Care India IPO opens on Jun 28, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Nephro Care India IPO and Visaman Global Sales IPO is Jul 02, 2024, and Jun 26, 2024, respectively.

	Nephro Care India IPO	Visaman Global Sales IPO
Anchor Bid Date	Jun 27, 2024
Issue Open	Jun 28, 2024	Jun 24, 2024
Issue Close	Jul 02, 2024	Jun 26, 2024
Basis Of Allotment (Tentative)	Jul 03, 2024	Jun 27, 2024
Initiation of Refunds (Tentative)	Jul 04, 2024	Jun 28, 2024
Credit of Share (Tentative)	Jul 04, 2024	Jun 28, 2024
Listing date (Tentative)	Jul 05, 2024	Jul 01, 2024
Anchor Lockin End date 1	Aug 02, 2024
Anchor Lockin End date 2	Oct 01, 2024

Financials

Nephro Care India IPO P/E ratio is 55.15, as compared to Visaman Global Sales IPO P/E ratio of 38.25.

Nephro Care India IPO

Visaman Global Sales IPO

Financial

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	2,029.85	831.11	462.93	112.84
Revenue	1,989.60	1,709.51	342.70	183.26
Profit After Tax	340.04	194.24	-0.98	8.87
Net Worth	1,392.32	243.76	49.52	1.50
Reserves and Surplus	1,332.81	193.76	-0.48	0.50
Total Borrowing		246.39	253.74	69.27
Amount in ₹ Lakhs

Visaman Global Sales Limited Financial Information (Restated)

Visaman Global Sales Limited's revenue increased by 16.04% and profit after tax (PAT) rose by 19.72% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	8,001.69	5,863.95	3,982.42	2,727.20
Revenue	20,691.39	37,605.01	32,407.29	13,636.19
Profit After Tax	101.61	113.33	94.66	33.47
Net Worth	1,095.31	993.70	660.38	565.72
Reserves and Surplus	395.31	293.70	180.38	85.72
Total Borrowing	5,690.85	4,345.69	1,386.10	710.34
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

85.02%

100.00%

Promoter Shareholding (Post-Issue)

61.39%

72.98%

P/E Ratio

55.15

38.25

Market Cap

₹148.38 Cr.

₹59.39 Cr.

ROE

41.57%%

9.28%%

ROCE

36.56%%

8.02%%

Debt/Equity

5.2

EPS

₹1.63

₹1.12

RoNW

24.42%%

9.28%%

Shares Offered

In the Nephro Care India IPO retail investors (RII) are offered 14,44,800 shares while in Visaman Global Sales IPO retail investors are offered 14,44,800 shares. Qualified institutional buyers (QIB) are offered 8,25,600 shares in Nephro Care India IPO and 0 shares in Visaman Global Sales IPO.

	Nephro Care India IPO	Visaman Global Sales IPO
Anchor Investor Reserveration	12,38,400 shares
Market Maker Reserveration	2,30,400 shares	1,92,000 shares
QIB	8,25,600 shares	0 shares
NII	6,19,200 shares	17,70,000 shares
RII	14,44,800 shares	17,70,000 shares
Employee	0 shares	0 shares
Others
Total	31,15,200 shares	35,40,000 shares

Bids Received (Subscription)

Nephro Care India IPO subscribed 715.78x in total, whereas Visaman Global Sales IPO subscribed 42.20x.

	Nephro Care India IPO	Visaman Global Sales IPO
QIB (times)	245.14x
NII (times)	1,787.19x	28.12x
Big NII (times)
Small NII (times)
RII (times)	634.12x	51.54x
Employee (times)
Other (times)
Total (times)	715.78x	42.20x

Compare with others

Nephro Care India IPO	Visaman Global Sales IPO
Sahaj Solar IPO	Ganesh Green Bharat IPO
Aelea Commodities IPO	Effwa Infra and Research IPO
Ganesh Green Bharat IPO	Ambey Laboratories IPO
Effwa Infra and Research IPO	Nephro Care India IPO
Ambey Laboratories IPO	Diensten Tech IPO
Diensten Tech IPO	Mason Infratech IPO
Visaman Global Sales IPO	Petro Carbon and Chemicals IPO
Mason Infratech IPO	Sylvan Plyboard IPO
Petro Carbon and Chemicals IPO	Shivalic Power Control IPO
Sylvan Plyboard IPO	Divine Power IPO

Comments

Add a public comment...